Nuveen Asset Management LLC decreased its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 5.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 360,112 shares of the aerospace company's stock after selling 19,940 shares during the period. Nuveen Asset Management LLC owned 0.27% of Leidos worth $51,878,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in Leidos by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 15,450,395 shares of the aerospace company's stock worth $2,225,784,000 after buying an additional 84,003 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Leidos by 13.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company's stock worth $571,216,000 after buying an additional 405,256 shares in the last quarter. Geode Capital Management LLC lifted its position in Leidos by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 3,393,313 shares of the aerospace company's stock worth $487,649,000 after buying an additional 27,410 shares in the last quarter. Invesco Ltd. lifted its position in Leidos by 35.0% during the 4th quarter. Invesco Ltd. now owns 2,630,448 shares of the aerospace company's stock worth $378,942,000 after buying an additional 682,532 shares in the last quarter. Finally, First Trust Advisors LP lifted its position in Leidos by 8.9% during the 4th quarter. First Trust Advisors LP now owns 1,901,433 shares of the aerospace company's stock worth $273,920,000 after buying an additional 155,481 shares in the last quarter. Institutional investors and hedge funds own 76.12% of the company's stock.
Analyst Ratings Changes
Several analysts have weighed in on LDOS shares. UBS Group boosted their price objective on Leidos from $149.00 to $168.00 and gave the stock a "neutral" rating in a report on Wednesday, May 7th. Wells Fargo & Company boosted their price objective on Leidos from $173.00 to $200.00 and gave the stock an "overweight" rating in a report on Thursday, May 8th. Royal Bank of Canada boosted their price objective on Leidos from $150.00 to $160.00 and gave the stock a "sector perform" rating in a report on Wednesday, May 7th. Truist Financial dropped their price objective on Leidos from $165.00 to $155.00 and set a "buy" rating for the company in a report on Monday, April 14th. Finally, Cantor Fitzgerald raised Leidos to a "strong-buy" rating in a report on Tuesday, February 25th. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Leidos has a consensus rating of "Moderate Buy" and a consensus price target of $180.69.
Read Our Latest Analysis on Leidos
Insider Buying and Selling
In other news, Director Gary Stephen May sold 2,128 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $131.24, for a total transaction of $279,278.72. Following the completion of the transaction, the director now directly owns 11,264 shares of the company's stock, valued at $1,478,287.36. This trade represents a 15.89% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gregory R. Dahlberg sold 1,250 shares of the firm's stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $154.55, for a total transaction of $193,187.50. Following the transaction, the director now directly owns 20,195 shares of the company's stock, valued at $3,121,137.25. This represents a 5.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.
Leidos Price Performance
NYSE LDOS opened at $159.08 on Monday. The business has a 50 day simple moving average of $142.23 and a 200 day simple moving average of $148.39. Leidos Holdings, Inc. has a 52-week low of $123.62 and a 52-week high of $202.90. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.21. The stock has a market cap of $20.48 billion, a price-to-earnings ratio of 17.22, a PEG ratio of 1.65 and a beta of 0.65.
Leidos (NYSE:LDOS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The aerospace company reported $2.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.47 by $0.50. Leidos had a return on equity of 30.93% and a net margin of 7.53%. The business had revenue of $4.25 billion during the quarter, compared to analysts' expectations of $4.11 billion. During the same period in the prior year, the business earned $2.29 EPS. Leidos's revenue for the quarter was up 6.8% compared to the same quarter last year. Analysts anticipate that Leidos Holdings, Inc. will post 10.62 earnings per share for the current fiscal year.
Leidos Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a dividend of $0.40 per share. The ex-dividend date is Monday, June 16th. This represents a $1.60 dividend on an annualized basis and a yield of 1.01%. Leidos's payout ratio is 16.10%.
About Leidos
(
Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report